Navigation Links
Bud Owen and Tony Click Join Clinverse, Inc. as Chief Financial Officer and Chief Technology Officer

Raleigh, NC (PRWEB) July 31, 2013

Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today the addition of Bud Owen as Chief Financial Officer and Tony Click as Chief Technology Officer. Both Bud and Tony bring extensive experience in their respective fields and serve as strategic members of the management team for the company.

In his role as CFO, Bud leads all financial aspects of the company, including accounting, treasury, tax and human resources activities. He is a veteran senior finance executive who was most recently with Clinipace, Inc., a global CRO. Prior to Clinipace, Bud served as CFO at a number of global companies in the software, web services, media and chemical industries. During his career, he has been either a principal or an advisor in more than 40 M&A transactions with a total transaction value of $1.5 billion. Bud has a Master of Business Administration from Queens University (Canada) and is an Ernst & Young (Toronto) alumni.

As Chief Technology Officer, Tony is responsible for all technical and architectural aspects of Clinverse’s software and eclinical commerce network. He brings more than 20 years of experience developing customer software solutions across many industries including finance, insurance, publishing, telecom, construction and utilities. His specialties include systems with high throughput, computationally intensive and ‘Big Data’ requirements. Prior to joining Clinverse, Tony provided outsourced CTO services for early-stage startups and served as the VP of Enterprise Architecture at Merkle, a database analytics company. Tony also ran his own consulting firm for 11 years, which delivered architectural and project management services. He received a Bachelor of Science in Electrical Engineering from Virginia Tech and a Master of Business Administration from Duke University’s Fuqua School of Business.

"We look forward to leveraging Bud and Tony’s industry knowledge and expertise to continue to grow our lead in the area of financial lifecycle systems for the clinical trials industry," said Steve Ayala, Clinverse co-founder and president. "Their leadership and experience are critical to our success as we continue to expand globally and seek to provide our customers with exceptional financial process automation solutions that fill an important, yet unmet need in clinical trials."

About Clinverse, Inc.

Clinverse, Inc. is a global technology and financial services company that delivers highly secure, cloud-based financial management and payment solutions for the clinical trials industry. Founded in 2008 and headquartered in Raleigh, NC, the company delivers clinical financial solutions through the only truly collaborative and transparent financial management and payment platform. Used by leading BioPharma companies, Clinverse has developed ClinPay®, a fully-configurable, game-changing SaaS-based platform which manages tens of millions of dollars in financial transactions for thousands of global sites while supporting payments in 140 different currencies. For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC
2. Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
3. Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013
4. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
5. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
6. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
7. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
8. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
9. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
10. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
11. Codexis Names Wes Bolsen VP and Chief Marketing Officer
Post Your Comments:
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that ... and invited investors to participate via webcast. ... 1, 2015 at 11.00 a.m. Eastern Time --> ... 1, 2015 at 11.00 a.m. Eastern Time --> ... NY      Tuesday, December 1, 2015 at 11.00 ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
Breaking Biology Technology:
(Date:11/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), the ... entry into the automotive market with a comprehensive and ... of consumer electronics human interface innovation. Synaptics, industry-leading touch ... the automotive industry and will be implemented in numerous ... , Japan , and ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):